MOGAD is now recognized as a distinct disease entity with an immunopathogenesis that differs from both multiple sclerosis (MS) and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) [1]. The gene discussed is AQP4; the disease is neuromyelitis optica.